Flageolet Bean (Phaseolus vulgaris)

Flageolet bean (Phaseolus vulgaris) extract contains alpha-amylase inhibitors that block carbohydrate digestion and absorption. Clinical studies demonstrate significant body fat reduction and weight management through reduced glucose uptake from starchy foods.

Origin & History

Flageolet bean (Phaseolus vulgaris) is a variety of the common bean plant originating from the Americas and cultivated worldwide, with the white kidney bean form commonly used for extracts. Standardized extracts are produced via aqueous (water) extraction from whole dried white kidney beans, yielding proprietary formulations rich in alpha-amylase inhibitors such as Phase 2 and Phaseolean®.

Historical & Cultural Context

No historical or traditional medicinal uses were identified in the available research. Current applications focus exclusively on modern nutraceutical uses for weight management and glycemic control developed through contemporary scientific investigation.

Health Benefits

• Body fat reduction: High-quality RCT (n=90) showed 2.95 kg fat loss over 12 weeks with Phase 2 extract (PMID: 38830962)
• Weight management support: 45-day RCT with Phaseolean® demonstrated significant weight reduction versus placebo (CTRI/2023/02/049440)
• Carbohydrate absorption reduction: Alpha-amylase inhibition prevents starch breakdown, reducing calorie absorption from complex carbohydrates
• Blood sugar management: May support glycemic control through reduced postprandial glycemia via enzyme inhibition
• Appetite regulation: Potentially suppresses ghrelin secretion, though evidence is preliminary

How It Works

Flageolet bean's alpha-amylase inhibitors, primarily phaseolamin, competitively bind to pancreatic alpha-amylase enzymes in the small intestine. This binding prevents the breakdown of complex carbohydrates into simple sugars, reducing glucose absorption and subsequent insulin response. The reduced caloric absorption from starches promotes lipolysis and fat oxidation pathways.

Scientific Research

A 12-week double-blind RCT (n=90) using Phase 2 white kidney bean extract showed significant body fat reduction of 2.95 kg versus placebo (PMID: 38830962). Additional trials including a 45-day study with Phaseolean® (CTRI/2023/02/049440) and meta-analyses (PMID: 29677119) confirm fat reduction benefits, though weight loss effects remain inconsistent across studies.

Clinical Summary

A high-quality RCT with 90 participants demonstrated 2.95 kg body fat loss over 12 weeks using Phase 2 flageolet bean extract (PMID: 38830962). A separate 45-day RCT with Phaseolean® showed significant weight reduction compared to placebo (CTRI/2023/02/049440). These controlled trials provide moderate evidence for weight management benefits, though longer-term studies are needed. The evidence is strongest for carbohydrate absorption inhibition and short-term weight loss outcomes.

Nutritional Profile

Flageolet beans (Phaseolus vulgaris) provide approximately 21-23g protein per 100g dry weight, with a moderate essential amino acid profile rich in lysine (~7.2g/100g protein) but limiting in methionine and cysteine (~2.1g/100g protein combined), typical of legumes. Carbohydrates comprise ~60-62g per 100g dry weight, predominantly complex starches (resistant starch ~4-6g/100g) and oligosaccharides (raffinose, stachyose ~3-5g/100g). Total dietary fiber ranges 15-18g per 100g dry weight, split roughly 70% insoluble (cellulose, hemicellulose) and 30% soluble (pectin) fractions. Fat content is low at 1.0-1.5g per 100g dry weight, predominantly polyunsaturated fatty acids. Key micronutrients per 100g dry weight include folate (~394 µg, ~99% DV), iron (~6.9 mg, ~38% DV, non-heme with bioavailability ~5-8% due to phytate inhibition), potassium (~1070 mg), magnesium (~138 mg), phosphorus (~407 mg), zinc (~2.8 mg, bioavailability reduced by ~25-35% due to phytic acid at ~6-10 mg/g), and manganese (~1.0 mg). Bioactive compounds include alpha-amylase inhibitor protein (Phase 2/Phaseolamin, concentrated in seed coat, active fraction ~0.5-2% of total protein by dry weight), phytic acid (1.0-1.5g/100g, acts as antinutrient reducing mineral bioavailability), polyphenols including condensed tannins (~2-4 mg catechin equivalents/g) and flavonoids (kaempferol, quercetin glycosides), and lectins (phytohemagglutinin, largely denatured upon thorough cooking). Bioavailability notes: soaking (8-12 hours) reduces phytic acid by ~30-40% and lectins significantly; pressure cooking reduces antinutrient load more effectively than boiling; protein digestibility-corrected amino acid score (PDCAAS) approximately 0.68-0.75 for cooked beans. The alpha-amylase inhibitory protein responsible for documented carbohydrate absorption reduction is heat-sensitive at temperatures above 80°C for extended periods, meaning raw or minimally processed preparations retain highest inhibitory activity.

Preparation & Dosage

Clinically studied standardized extracts (Phase 2, Phaseolean®) range from 700-1000 mg three times daily (2100-3000 mg/day) taken before carbohydrate-rich meals. Lower doses of 1000 mg twice daily (2000 mg/day) showed weight loss trends. Only proprietary aqueous extracts standardized for alpha-amylase inhibition (e.g., 20,000 units/g) have been studied. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, chromium picolinate, garcinia cambogia, glucomannan fiber, berberine

Safety & Interactions

Flageolet bean extract is generally well-tolerated with mild gastrointestinal effects like bloating or flatulence being most common. It may interact with diabetes medications by enhancing blood sugar-lowering effects, requiring glucose monitoring adjustments. Individuals with kidney disease should use caution due to potential effects on mineral absorption. Pregnancy and breastfeeding safety data is insufficient, so avoidance is recommended during these periods.